Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03529994 · ClinicalTrials.gov registry record
Work of Breathing and Oxygen Saturation in Infants Receiving High Flow Nasal Cannula (HFNC)
A clinical trial, sponsored by Christiana Care Health Services.
- Completed
- Registry status
- 30
- Enrollment target
NCT03529994: Completed study, sponsored by Christiana Care Health Services.
NCT03529994 is a clinical trial that has completed, run by Christiana Care Health Services. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03529994 has completed, sponsored by Christiana Care Health Services.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
The purpose of this study is to compare work of breathing on different levels of high flow respiratory support on infants born between 27 and 37 weeks gestation.
Primary Outcome
Altering HFNC flow rates and its effect on work of breathing indices in preterm infants with respiratory insufficiency.
Interventions
- OTHER Enrollment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2018-04-15 |
| Est. Completion | 2019-08-01 |
What the finished NCT03529994 record still lists
NCT03529994 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Enrollment is the first listed.
NCT03529994 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03529994 about?
NCT03529994 is a clinical study titled "Work of Breathing and Oxygen Saturation in Infants Receiving High Flow Nasal Cannula (HFNC)". The purpose of this study is to compare work of breathing on different levels of high flow respiratory support on infants born between 27 and 37 weeks gestation.
What is the current status of trial NCT03529994?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2018-04-15. Estimated completion is 2019-08-01.
What interventions are being tested in trial NCT03529994?
The interventions under investigation include: Enrollment (OTHER).
Who is sponsoring clinical trial NCT03529994?
This trial is sponsored by Christiana Care Health Services, which has 82 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI